Dr. Mark Fishman of the Novartis Institutes for Biomedical Research, discusses several current programs in drug discovery that promise to change the practice of medicine. Each grew from basic science
Statement of Lawrence Goldstein, Ph.D. Distinguished Professor, Dept. of Cellular and Molecular Medicine, Dept. of Neurosciences Director, UC San Diego Stem Cell Program Scientific Director, Sanford Consortium for Regenerative Medicine
